CONHealthcare · Medical Care FacilitiesThe 9 Wall Street analysts covering Concentra Group Holdings Parent, Inc. hold a median 12-month price target of $40 — +12.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 95 of 100 as at 13 Aug 2026 — among the strongest tenth. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Concentra Group Holdings Parent, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Revisions (97): Analysts have, on balance, been raising their forecasts.
Volatility (41): The share price moves around a lot.
Size (26): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on CON, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +12.9% from it.
Of the 20 most recent actions, 4 moved their price target up and 0 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 11 Aug 2026 | Wells Fargo | Maintains | Overweight | $28 → $40 |
| 10 Aug 2026 | RBC Capital | Maintains | Outperform | $36 → $42 |
| 10 Aug 2026 | Truist Securities | Maintains | Buy | $37 → $42 |
| 14 July 2026 | Truist Securities | Maintains | Buy | — |
| 14 July 2026 | Truist Securities | Maintains | Buy | $31 → $37 |
| 1 July 2026 | William Blair | Initiates | Outperform | — |
| 1 July 2026 | William Blair | Initiates | Outperform | — |
| 5 June 2026 | Goldman Sachs | Initiates | Buy | — |
| 11 May 2026 | Truist Securities | Reiterates | Buy | — |
| 5 Mar 2026 | Wells Fargo | Maintains | Overweight | — |
| 2 Feb 2026 | RBC Capital | Maintains | Outperform | — |
| 18 Sept 2025 | JP Morgan | Assumes | Overweight | $31 |
| 19 Mar 2025 | JP Morgan | Maintains | Overweight | — |
| 12 Mar 2025 | Wells Fargo | Maintains | Overweight | — |
| 23 Jan 2025 | B of A Securities | Maintains | Buy | — |
| 23 Jan 2025 | RBC Capital | Reiterates | Outperform | — |
| 16 Dec 2024 | B of A Securities | Upgrade | Buy | — |
| 4 Nov 2024 | RBC Capital | Maintains | Outperform | — |
| 7 Oct 2024 | B of A Securities | Downgrade | Neutral | — |
| 20 Aug 2024 | RBC Capital | Initiates | Outperform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CON appears on the weeks it earns a place.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 35% of US stocks
Cheaper than 54% of US stocks
Cheaper than 11% of US stocks
Cheaper than 26% of US stocks
Higher than 53% of US stocks
Higher than 74% of US stocks
Higher than 37% of US stocks
Higher than 78% of US stocks
Higher than 67% of US stocks
Higher than 92% of US stocks
Higher than 88% of US stocks
Higher than 15% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Concentra Group Holdings Parent, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
A Zacks Investment Research article examines whether Concentra Group (CON) or Medpace (MEDP) currently offers a better value opportunity for investors in the Medical Services sector.
Why it matters — CON watchers would care because the article positions Concentra Group against a peer, potentially influencing investor perception of the company's relative value.
Concentra Group Holdings Parent, Inc. (CON) reached a 52-week high, and Zacks Investment Research examined the company's fundamentals to assess whether further gains are possible.
Why it matters — A 52-week high signals strong recent price momentum, and investors would want to know whether fundamentals support continued growth or if the stock may be due for a pullback.
Concentra Group Holdings Parent, Inc. announced that its management team will present at three upcoming investor conferences in August and September 2026, including the Bank of America Virtual SMID Cap Conference, the RBC Nashville Healthcare Bus Tour, and the Wells Fargo Healthcare Conference.
Why it matters — The scheduled appearances give CON watchers an opportunity to hear directly from management about the company's strategy and outlook at multiple industry investor events.
Concentra Group Holdings Parent reported higher second-quarter revenue, earnings and cash flow. The company also announced that CEO Keith Newton will transition to Executive Chairman on Nov. 1, with President and CFO Matt DiCanio becoming President and CEO.
Why it matters — CON watchers would note the company's improving financial performance alongside a planned leadership succession that keeps both executives involved.
Concentra Group Holdings Parent, Inc. held its Q2 2026 earnings call, and a transcript of that call was published by Seeking Alpha. The transcript covers the company's second-quarter 2026 financial results and management commentary.
Why it matters — CON watchers rely on the earnings call transcript for management's detailed discussion of second-quarter 2026 financial performance and business outlook.
The 9 Wall Street analysts covering Concentra Group Holdings Parent, Inc. have a median 12-month price target of $40, with estimates ranging from $34 to $42. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 9 analysts covering Concentra Group Holdings Parent, Inc., 9 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Concentra Group Holdings Parent, Inc. 95 out of 100 across roughly 4,600 US stocks as at 13 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 13 Aug 2026, Concentra Group Holdings Parent, Inc. ranks 95 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (97 of 100).
No one can know that. What the data says: the median 12-month target from 9 analysts implies +12.9% from the last close, and Ticker Nerd's factor model ranks Concentra Group Holdings Parent, Inc. 95 out of 100 as at 13 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Concentra Group Holdings Parent, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CON are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $34 to $42 over the next 12 months.
Concentra Group Holdings Parent, Inc. returned +53.1% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Concentra Group Holdings Inc. is a prominent player in the healthcare and occupational health services industry.
The most recent item we track (Zacks Investment Research, 10 Aug 2026): "CON or MEDP: Which Is the Better Value Stock Right Now?". A Zacks Investment Research article examines whether Concentra Group (CON) or Medpace (MEDP) currently offers a better value opportunity for investors in the Medical Services sector.
Concentra Group Holdings Inc. is a prominent player in the healthcare and occupational health services industry. As a subsidiary of Select Medical Holdings Corporation, Concentra provides a comprehensive range of medical services, primarily focusing on occupational medicine, urgent care, and physical therapy. It serves a diverse array of clients, including employees of large corporations, small businesses, and government entities. The company’s primary aim is to ensure workforce health and productivity by offering preventive care, injury treatment, and wellness programs. Through its extensive network of medical centers and on-site clinics, Concentra plays a crucial role in reducing workplace injuries and managing employee health, directly impacting industries that rely heavily on workforce efficiency such as manufacturing, transportation, and construction. Moreover, by delivering critical health services, the company contributes significantly to the broader healthcare ecosystem. Founded with a mission to provide convenient and effective healthcare solutions, Concentra Group Holdings Inc. continues to adapt to evolving healthcare demands, reinforcing its position as a key participant in the occupational health market.
CEO Mr. William Keith Newton · 9,967 employees · United States · https://www.concentra.com